TABLE 4.
Percentage change from 2 wk2 |
|||||||
13 wk |
52 wk |
P3 |
|||||
Calcium group (n = 25) | Placebo group (n = 27) | Calcium group (n = 39) | Placebo group (n = 37) | Time | Group | Overall calcium effect4 | |
Total hip | |||||||
BMC | −4.0 ± 1.25 | −6.2 ± 1.56 | −7.0 ± 1.66 | −8.3 ± 1.56 | ≤0.001 | 0.005 | −10.7 (−18.1, −3.4) |
BA | −0.7 ± 1.1 | −2.0 ± 1.0 | −1.3 ± 1.1 | −1.9 ± 1.1 | 0.08 | 0.05 | −3.8 (−7.6, 0.0) |
BMD | −3.3 ± 0.97 | −4.2 ± 0.86 | −5.8 ± 0.968 | −6.4 ± 0.969 | ≤0.001 | 0.01 | −6.9 (−12.1, −1.7) |
SA-BMC | −3.1 ± 0.97 | −3.7 ± 0.86 | −5.5 ± 0.968 | −6.0 ± 0.869 | ≤0.001 | 0.05 | −6.0 (−12.0, 0.0) |
Femoral shaft | |||||||
BMC | −2.6 ± 1.5 | −5.6 ± 1.46 | −5.2 ± 1.57 | −7.0 ± 1.46 | ≤0.001 | 0.003 | −9.3 (−15.3, −3.3) |
BA | 0.3 ± 1.0 | −1.7 ± 1.0 | 0.0 ± 1.0 | −1.0 ± 1.0 | 0.6 | 0.3 | −1.6 (−4.7, 1.5) |
BMD | −2.9 ± 0.87 | −3.9 ± 0.86 | −5.2 ± 0.868 | −6.0 ± 0.869 | ≤0.001 | 0.01 | −7.7 (−13.4, −1.9) |
SA-BMC | −2.9 ± 0.87 | −3.6 ± 0.86 | −5.2 ± 0.868 | −5.8 ± 0.869 | ≤0.001 | 0.02 | −7.3 (−13.3, −1.3) |
Trochanter | |||||||
BMC | −6.1 ± 2.9 | −6.9 ± 2.75 | −10.4 ± 2.97 | −10.3 ± 2.87 | ≤0.001 | 0.02 | −15.2 (−27.7, −2.7) |
BA | −2.0 ± 2.5 | −2.1 ± 2.4 | −3.6 ± 2.5 | −2.4 ± 2.4 | 0.2 | 0.05 | −7.7 (−15.6, 0.2) |
BMD | −4.1 ± 1.37 | −4.8 ± 1.36 | −6.8 ± 1.36 | −7.9 ± 1.369 | ≤0.001 | 0.02 | −7.5 (−13.7, −1.3) |
SA-BMC | −4.1 ± 1.47 | −4.7 ± 1.37 | −6.7 ± 1.46 | −7.8 ± 1.369 | ≤0.001 | 0.02 | −7.1 (−13.1, −1.1) |
Femoral neck | |||||||
BMC | −5.1 ± 2.05 | −6.9 ± 1.97 | −8.8 ± 2.06 | −8.9 ± 2.06 | ≤0.001 | 0.07 | −8.5 (−17.7, 0.7) |
BA | −1.0 ± 1.7 | −2.6 ± 1.6 | −1.1 ± 1.7 | −2.8 ± 1.6 | 0.2 | 0.6 | −2.1 (−9.1, 4.9) |
BMD | −4.2 ± 1.17 | −4.3 ± 1.16 | −7.6 ± 1.169 | −6.1 ± 1.16 | ≤0.001 | 0.02 | −6.4 (−11.6, −1.2) |
SA-BMC | −4.2 ± 1.27 | −4.2 ± 1.16 | −7.6 ± 1.269 | −6.1 ± 1.16 | ≤0.001 | 0.02 | −6.0 (−11.4, −0.6) |
Hip scans were conducted by dual-energy X-ray absorptiometry. BMC, bone mineral content; BA, bone area; BMD, bone mineral density; SA-BMC, size-adjusted BMC derived by including BA and body weight in the hierarchical ANCOVA model. Body weight was not a significant independent variable of bone mineral status at the hip and was removed from the models presented.
All values are means ± SEs from hierarchical ANOVA and ANCOVA models with continuous variables in natural logarithms that involve subjects nested by group, time, and time × group interaction terms.
P values for each component from the model without the interaction term. The time × group interaction term was not significant at any site in the hip.
Overall magnitude of group differences expressed as mean (95% CI) percentage differences obtained from hierarchical models without interaction terms and representing the average calcium effect over all 3 time points.
Significance of differences from 2 to 13 and 52 wk within each group: 5P ≤ 0.05, 6P ≤ 0.001, 7P ≤ 0.01.
Significance of differences from 13 to 52 wk within each group: 8P ≤ 0.01, 9P ≤ 0.05.